Relay Therapeutics, Inc. (RLAY)
$17.36-3.45%Close
SELLRECOVERY · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.0B
- Beta
- 1.73
- P/E (TTM)
- -11.06
- Short % float
- 34.34%
- Days to cover
- 12.6
- SI change
- +5.1%
- 1W
- -7.36%
- 1M
- -8.92%
- vs SPY 1W
- -7.23%
- vs SPY 1M
- -11.43%
Industry peers
FMP comparable companies · ranked by market cap
- RVMDSELLRevolution Medicines, Inc.$42.5BRECOVERYQ 30$199.87-2.84%
- KYMRSELLKymera Therapeutics, Inc.$8.7BBEARQ 25$105.98-4.82%
- ERASSELLErasca, Inc.$5.0BRECOVERYQ 4$14.30-4.40%
- TNGXSELLTango Therapeutics, Inc.$3.6BRECOVERYQ 23$21.90-8.07%
- IDYASELLIDEAYA Biosciences, Inc.$3.5BBEARQ 25$36.63-4.99%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.60-0.14%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$11.98-4.23%
- TYRASELLTyra Biosciences, Inc.$1.2BCRISISQ 4$20.24-5.31%
- AVBPSELLArriVent BioPharma, Inc.$703MCRISISQ -6$15.09-2.25%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RLAY?
- LOPJLB’s latest quantitative signal on Relay Therapeutics, Inc. (RLAY) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is RLAY in?
- Relay Therapeutics, Inc. (RLAY) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Relay Therapeutics, Inc. (RLAY) do?
- Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administere…